Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Enhanced Biochemical Response on Clinical Outcomes in Patients With Primary Biliary Cholangitis: A Bidirectional Cohort Study

NCT07449793 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07449793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Enhanced Biochemical Response on Clinical Outcomes in Patients With Primary Biliary Cholangitis: A Bidirectional Cohort Study
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2026
Completion date
January 31, 2028
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary biliary cholangitis, primary biliary cholangitis (pbc)